Faralimomab, CAS 167816-91-3

Product Description: Faralimomab (64G12) is an immunomodulator, and a murine anti-IFNA1 IgG1 mAb[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Pelletier J P R, et al. Passive monoclonal and polyclonal antibody therapies[M]//Immunologic Concepts in Transfusion Medicine. Elsevier, 2020: 251-348. /[2]Pelletier J P R, et al. Passive monoclonal and polyclonal antibody therapies[M]//Immunologic Concepts in Transfusion Medicine. Elsevier, 2020: 251-348.

CAS Number: 167816-91-3

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: IFNAR

• SKU: MEXHY-P99611-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99611-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated